Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study

The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group...

Full description

Saved in:

Bibliographic Details
Published in	Journal of nuclear cardiology Vol. 30; no. 4; pp. 1642 - 1652
Main Authors	Boczar, Kevin E., Beanlands, Rob S., Glassman, Steven J., Wang, Jerry, Zeng, Wanzhen, deKemp, Robert A., Ward, Natalie C., Fehlmann, Christophe A., Wells, George A., Karsh, Jacob, Dwivedi, Girish
Format	Journal Article
Language	English
Published	Cham Elsevier Inc 01.08.2023 Springer International Publishing Springer Nature B.V
Subjects	Anti-Inflammatory Agents - therapeutic use Arthritis, Psoriatic - diagnostic imaging Arthritis, Psoriatic - drug therapy Biological Factors - therapeutic use Cardiology cardiovascular disease Coronary vessels Fluorodeoxyglucose F18 - therapeutic use Humans Imaging inflammation Inflammation - diagnostic imaging Medicine Medicine & Public Health Nuclear Medicine Original Original Article PET imaging Positron-Emission Tomography Prospective Studies Psoriasis Psoriasis - diagnostic imaging Psoriasis - drug therapy Psoriatic arthritis Radiology cardiovascular disease PET imaging inflammation Psoriatic arthritis
Online Access	Get full text

Cover

Loading…

Abstract	The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3). Target-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBRmax) was measured to assess vascular inflammation. 82Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBRmax: − .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBRmax: .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response. In a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders.
AbstractList	The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3). Target-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBR ) was measured to assess vascular inflammation. Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBR : - .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBR : .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response. In a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders. The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3). Target-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBRmax) was measured to assess vascular inflammation. 82Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBRmax: − .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBRmax: .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response. In a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders. Aim The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82 Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3). Methods and Results Target-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBR max ) was measured to assess vascular inflammation. 82 Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBR max : − .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBR max : .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response. Conclusion In a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders. AimThe aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3).Methods and ResultsTarget-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBRmax) was measured to assess vascular inflammation. 82Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBRmax: − .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBRmax: .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response.ConclusionIn a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders. The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3).AIMThe aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3).Target-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBRmax) was measured to assess vascular inflammation. 82Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBRmax: - .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBRmax: .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response.METHODS AND RESULTSTarget-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBRmax) was measured to assess vascular inflammation. 82Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBRmax: - .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBRmax: .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response.In a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders.CONCLUSIONIn a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders.
Author	Beanlands, Rob S. Fehlmann, Christophe A. Dwivedi, Girish Glassman, Steven J. Karsh, Jacob Zeng, Wanzhen Ward, Natalie C. Wells, George A. Wang, Jerry Boczar, Kevin E. deKemp, Robert A.
Author_xml	– sequence: 1 givenname: Kevin E. surname: Boczar fullname: Boczar, Kevin E. organization: University of Ottawa Heart Institute, Ottawa, ON, Canada – sequence: 2 givenname: Rob S. surname: Beanlands fullname: Beanlands, Rob S. organization: University of Ottawa Heart Institute, Ottawa, ON, Canada – sequence: 3 givenname: Steven J. surname: Glassman fullname: Glassman, Steven J. organization: Division of Dermatology, The Ottawa Hospital, Ottawa, ON, Canada – sequence: 4 givenname: Jerry surname: Wang fullname: Wang, Jerry organization: University of Ottawa Heart Institute, Ottawa, ON, Canada – sequence: 5 givenname: Wanzhen surname: Zeng fullname: Zeng, Wanzhen organization: University of Ottawa Heart Institute, Ottawa, ON, Canada – sequence: 6 givenname: Robert A. surname: deKemp fullname: deKemp, Robert A. organization: University of Ottawa Heart Institute, Ottawa, ON, Canada – sequence: 7 givenname: Natalie C. surname: Ward fullname: Ward, Natalie C. organization: School of Medicine, University of Western Australia, Perth, WA, Australia – sequence: 8 givenname: Christophe A. surname: Fehlmann fullname: Fehlmann, Christophe A. organization: School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada – sequence: 9 givenname: George A. surname: Wells fullname: Wells, George A. organization: University of Ottawa Heart Institute, Ottawa, ON, Canada – sequence: 10 givenname: Jacob surname: Karsh fullname: Karsh, Jacob organization: Division of Rheumatology, The Ottawa Hospital, Ottawa, ON, Canada – sequence: 11 givenname: Girish surname: Dwivedi fullname: Dwivedi, Girish email: girish.dwivedi@perkins.uwa.edu.au organization: University of Ottawa Heart Institute, Ottawa, ON, Canada
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36754934$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uktv1DAYtFARbRf-AAdkiQuXgB9xbCMktCptQaoEh3K2HMfZdZXYwXYW7b_HS1oePezJn-yZ0XwzPgcnPngLwEuM3mKE-LuECWWoQoRWiBJUV-IJOMOMkqphDJ-UGXFcUSbwKThP6Q4hJKmUz8ApbTirJa3PQFr77Crn-0GPo84h7qHte2syDD1sXRjCxhmYtzbqaQ-dh5POzvqc4E-Xt3BKIbpyY2DnktXJvodrOMWQpiLhdhaasA0xw6tP1_Db5S1Mee72z8HTXg_Jvrg_V-D71eXtxefq5uv1l4v1TWUYEblqbUsaYSQWlJeZ18JwLVuOCbNSU9oZ1vWGS9lr2iHUM8G7RtumN7QRjAu6Ah8X3WluR9uZYjvqQU3RjTruVdBO_f_i3VZtwk5hRDnBJdcVeHOvEMOP2aasRpeMHQbtbZiTIry4kqwpoa_A60fQuzBHX_ZTRNSE1RTRA-rVv5b-eHkopADEAjAlxBRtr4zLJeBwcOiGYk0duldL96p4VL-7V4d1ySPqg_pREl1IqYD9xsa_to-yPiwsW-rbucJKpvwKYzsXS_GqC-4Y_ReJfNXA
CitedBy_id	crossref_primary_10_1007_s12350_023_03250_2 crossref_primary_10_1080_1744666X_2023_2249235 crossref_primary_10_1007_s40336_024_00630_7 crossref_primary_10_1093_rheumatology_keae450 crossref_primary_10_1152_ajpheart_00744_2023 crossref_primary_10_1136_bmjopen_2023_074463
Cites_doi	10.1016/j.jcmg.2010.04.007 10.1016/S0140-6736(13)61754-7 10.1161/CIRCIMAGING.116.004713 10.1016/j.cyto.2014.12.014 10.1186/s13550-016-0225-4 10.1002/art.21972 10.1161/CIRCIMAGING.118.007849 10.2967/jnumed.108.056325 10.1016/j.atherosclerosis.2012.06.068 10.1161/ATVBAHA.115.306460 10.1016/j.jacc.2018.01.062 10.1001/jamadermatol.2013.5015 10.1016/j.jacc.2006.05.076 10.7150/thno.6592 10.1161/CIRCIMAGING.117.007394 10.1007/s00259-007-0478-2 10.1001/archderm.143.12.1493 10.1016/j.atherosclerosis.2019.08.009 10.1152/ajpheart.00774.2016 10.1161/01.CIR.0000020548.60110.76 10.1001/jama.296.14.1735 10.1016/j.jcmg.2013.08.006 10.1007/s10067-011-1692-7 10.1016/j.jcmg.2011.08.007 10.1161/CIRCULATIONAHA.112.120410 10.2967/jnumed.109.065151 10.1186/s13550-016-0215-6 10.2174/1574887113666180314105511 10.1016/j.jaad.2018.03.011 10.1016/j.ijcard.2018.05.057 10.1007/s00259-008-0793-2 10.1111/j.1468-3083.2009.03562.x 10.1002/ana.23553 10.1038/nrcardio.2014.80 10.1093/eurheartj/ehp567 10.12659/PJR.883763 10.1001/jamacardio.2017.1213 10.1093/eurheartj/ehw147 10.1111/bjd.13715 10.1016/j.jacc.2013.04.066 10.1093/rheumatology/keg217
ContentType	Journal Article
Copyright	2023 THE AUTHORS. Published by ELSEVIER INC. on behalf of American Society of Nuclear Cardiology The Author(s) 2023. corrected publication 2023 2023. The Author(s). The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023, corrected publication 2023
Copyright_xml	– notice: 2023 THE AUTHORS. Published by ELSEVIER INC. on behalf of American Society of Nuclear Cardiology – notice: The Author(s) 2023. corrected publication 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023, corrected publication 2023
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 5PM
DOI	10.1007/s12350-023-03204-8
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic
DatabaseTitleList	MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic
Database_xml	– sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1532-6551
EndPage	1652
ExternalDocumentID	PMC10372102 36754934 10_1007_s12350_023_03204_8 S1071358124000643
Genre	Journal Article
GroupedDBID	--- --K -EM -Y2 .GJ 06D 0R~ 0VY 199 1B1 1N0 2.D 203 29L 29~ 2JN 2JY 2KG 2LR 2VQ 30V 3V. 4.4 406 408 40D 53G 5GY 5VS 67Z 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 96X AAAVM AABHQ AABYN AAEDT AAEOY AAFGU AAHNG AAIAL AAJKR AAKSU AALRI AANXM AANZL AAQFI AAQXK AARHV AARTL AATNV AATVU AAUYE AAWCG AAWTL AAXUO AAYFA AAYIU AAYQN AAYTO AAZMS ABAKF ABDZT ABECU ABFGW ABFTV ABHLI ABIPD ABJNI ABJOX ABKAS ABKCH ABMAC ABMQK ABMYL ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABXPI ACBMV ACBRV ACBXY ACBYP ACGFO ACGFS ACHSB ACHVE ACHXU ACIGE ACIHN ACIPQ ACKNC ACMDZ ACMLO ACOKC ACREN ACTTH ACUDM ACVWB ACWMK ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADMUD ADOXG ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEEQQ AEFQL AEFTE AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETCA AEVLU AEVTX AEXYK AFAFS AFBBN AFKRA AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AITUG AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC AKRWK ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AMXSW AMYLF AMYQR ANMIH AOCGG ASPBG AVWKF AXYYD AZFZN BA0 BBWZM BENPR BGNMA BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 EO8 EO9 ESBYG EX3 F5P FDB FEDTE FERAY FFXSO FGOYB FIGPU FINBP FNLPD FRRFC FSGXE FYUFA G-Q GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IHE IKXTQ IMOTQ ITM IWAJR IXC I~X J-C J0Z J5H JBSCW JZLTJ KOV KPH LLZTM M1P M41 M4Y MA- N2Q N9A NAPCQ NDZJH NF0 NQ- NQJWS NU0 O9- O93 O9G O9I O9J P19 P2P P9S PQQKQ PROAC PSQYO PT4 PT5 Q2X R2- R89 R9I RHV RIG RNI ROL RPZ RSV RZK S1Z S26 S27 S28 S37 S3B SCLPG SDE SDG SDH SEW SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD SSZ STPWE SV3 SZ9 SZN T13 T16 TSG TT1 U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 WOW Z45 Z7U Z7X Z7Y Z82 Z87 ZMTXR ZOVNA ~A9 AAJBT AAYZH ABQSL ABWVN ACRPL ADNMO AFJKZ ALIPV AMRAJ C6C H13 NPVJJ SJN AAYXX ABFSG ACSTC ADHKG AEZWR AFHIU AGCQF AGQPQ AHPBZ AHWEU AIGII AIXLP APXCP AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM EFKBS K9. 7X8 5PM
ID	FETCH-LOGICAL-c528t-beb268c91837beb748c7a9b7125e9a33dc5dfc799fa3d00f587d6ae6fc3685783
IEDL.DBID	C6C
ISSN	1071-3581 1532-6551
IngestDate	Thu Aug 21 18:36:44 EDT 2025 Fri Jul 11 02:40:31 EDT 2025 Wed Aug 13 07:02:32 EDT 2025 Thu Apr 03 07:02:31 EDT 2025 Tue Jul 01 01:28:52 EDT 2025 Thu Apr 24 23:00:12 EDT 2025 Fri Feb 21 02:42:46 EST 2025 Sat Mar 16 16:14:37 EDT 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	cardiovascular disease PET imaging inflammation Psoriatic arthritis
Language	English
License	2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c528t-beb268c91837beb748c7a9b7125e9a33dc5dfc799fa3d00f587d6ae6fc3685783
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://doi.org/10.1007/s12350-023-03204-8
PMID	36754934
PQID	2842543035
PQPubID	54088
PageCount	11
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_10372102 proquest_miscellaneous_2774895615 proquest_journals_2842543035 pubmed_primary_36754934 crossref_citationtrail_10_1007_s12350_023_03204_8 crossref_primary_10_1007_s12350_023_03204_8 springer_journals_10_1007_s12350_023_03204_8 elsevier_sciencedirect_doi_10_1007_s12350_023_03204_8
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2023-08-01
PublicationDateYYYYMMDD	2023-08-01
PublicationDate_xml	– month: 08 year: 2023 text: 2023-08-01 day: 01
PublicationDecade	2020
PublicationPlace	Cham
PublicationPlace_xml	– name: Cham – name: United States – name: New York
PublicationTitle	Journal of nuclear cardiology
PublicationTitleAbbrev	J. Nucl. Cardiol
PublicationTitleAlternate	J Nucl Cardiol
PublicationYear	2023
Publisher	Elsevier Inc Springer International Publishing Springer Nature B.V
Publisher_xml	– name: Elsevier Inc – name: Springer International Publishing – name: Springer Nature B.V
References	Daghem, Newby (bib6) 2018; 11 Rudd, Warburton, Fryer, Jones, Clark, Antoun, Johnstrom, Davenport, Kirkpatrick, Arch, Pickard, Weissberg (bib10) 2002; 105 Harrington, Dey, Yunus, Joshi, Mehta (bib31) 2017; 312 deKemp, Klein, Beanlands (bib19) 2016; 6 Germino, Ropchan, Mulnix, Fontaine, Nabulsi, Ackah, Feringa, Sinusas, Liu, Carson (bib20) 2016; 6 Yeung, Takeshita, Mehta, Kimmel, Ogdie, Margolis, Shin, Attor, Troxel, Gelfand (bib3) 2013; 149 Figueroa, Abdelbaky, Truong, Corsini, MacNabb, Lavender, Lawler, Grinspoon, Brady, Nasir, Hoffmann, Tawakol (bib13) 2013; 6 Peluso, Caso, Tasso, Ambrosino, Dario Di Minno, Lupoli (bib2) 2018; 13 Tawakol, Migrino, Bashian, Bedri, Vermylen, Cury, Yates, LaMuraglia, Furie, Houser, Gewirtz, Muller, Brady, Fischman (bib11) 2006; 48 Schindler, Schelbert, Quercioli, Dilsizian (bib18) 2010; 3 Joseph, Tawakol (bib42) 2016; 37 Maki-Petaja, Elkhawad, Cheriyan, Joshi, Ostor, Hall, Rudd, Wilkinson (bib32) 2012; 126 Mehta, Shin, Joshi, Dey, Armstrong, Duffin, Fuxench, Harrington, Hubbard, Kalb, Menter, Rader, Reilly, Simpson, Takeshita, Torigian, Werner, Troxel, Tyring, Vanderbeek, Van Voorhees, Playford, Ahlman, Alavi, Gelfand (bib35) 2018; 11 Mehta, Azfar, Shin, Neimann, Troxel, Gelfand (bib29) 2010; 31 Dey, Joshi, Chaturvedi, Lerman, Aberra, Rodante, Teague, Harrington, Rivers, Chung, Kabbany, Natarajan, Silverman, Ng, Sanda, Sorokin, Baumer, Gerson, Prussick, Ehrlich, Green, Lockshin, Ahlman, Playford, Gelfand, Mehta (bib34) 2017; 2 Khraishi, MacDonald, Rampakakis, Vaillancourt, Sampalis (bib23) 2011; 30 Fox, Strauss (bib40) 2009; 50 Lortie, Beanlands, Yoshinaga, Klein, Dasilva, DeKemp (bib25) 2007; 34 Goff, Karimkhani, Boyers, Weinstock, Lott, Hay, Coffeng, Norton, Naldi, Dunnick, Armstrong, Dellavalle (bib27) 2015; 172 Rominger, Saam, Wolpers, Cyran, Schmidt, Foerster, Nikolaou, Reiser, Bartenstein, Hacker (bib14) 2009; 50 Anagnostopoulos, Almonacid, El Fakhri, Curillova, Sitek, Roughton, Dorbala, Popma, Di Carli (bib22) 2008; 35 Mehta, Li, Krishnamoorthy, Yu, Farver, Rodrigues, Raper, Wilcox, Baer, DerOhannesian, Wolfe, Reilly, Rader, VanVoorhees, Gelfand (bib30) 2012; 224 Baliwag, Barnes, Johnston (bib7) 2015; 73 Taylor, Gladman, Helliwell, Marchesoni, Mease, Mielants (bib21) 2006; 54 Kim, Lee, Pak, Han, Kim, Kim, Ko, Kim, Kim (bib33) 2019; 80 Gelfand, Troxel, Lewis, Kurd, Shin, Wang, Margolis, Strom (bib4) 2007; 143 Li, Rosenkrans, Wang, Cai (bib37) 2020; 12 Marnane, Merwick, Sheehan, Hannon, Foran, Grant, Dolan, Moroney, Murphy, O’Rourke, O’Malley, O’Donohoe, McDonnell, Noone, Barry, Crowe, Kavanagh, O’Connell, Kelly (bib15) 2012; 71 Gelfand, Neimann, Shin, Wang, Margolis, Troxel (bib28) 2006; 296 Bengel (bib36) 2016; 9 Chih, Chong, Erthal, deKemp, Davies, Stadnick, So, Overgaard, Wells, Mielniczuk, Beanlands (bib26) 2018; 71 Piaserico, Osto, Famoso, Montisci, De Michieli, Zanetti, Iliceto, Tona (bib9) 2019; 289 Cocker, Spence, Hammond, deKemp, Lum, Wells (bib12) 2018; 271 Tawakol, Fayad, Mogg, Alon, Klimas, Dansky, Subramanian, Abdelbaky, Rudd, Farkouh, Nunes, Beals, Shankar (bib16) 2013; 62 Naik, Natarajan, Stansky, Ahlman, Teague, Salahuddin, Ng, Joshi, Krishnamoorthy, Dave, Rose, Doveikis, Playford, Prussick, Ehrlich, Kaplan, Lockshin, Gelfand, Mehta (bib8) 2015; 35 Tarkin, Joshi, Rudd (bib38) 2014; 11 McHugh, Balachrishnan, Jones (bib5) 2003; 42 Wu, Li, Niu, Chen (bib41) 2013; 3 Joshi, Vesey, Williams, Shah, Calvert, Craighead, Yeoh, Wallace, Salter, Fletcher, van Beek, Flapan, Uren, Behan, Cruden, Mills, Fox, Rudd, Dweck, Newby (bib39) 2014; 383 Puzenat, Bronsard, Prey, Gourraud, Aractingi, Bagot, Cribier, Joly, Jullien, Le Maitre, Paul, Richard-Lallemand, Ortonne, Aubin (bib24) 2010; 24 Sankowski, Lebkowska, Cwikla, Walecka, Walecki (bib1) 2013; 78 Mizoguchi, Tahara, Tahara, Nitta, Kodama, Oba, Mawatari, Yasukawa, Kaida, Ishibashi, Hayabuchi, Harada, Ikeda, Yamagishi, Imaizumi (bib17) 2011; 4 Maki-Petaja, Elkhawad, Cheriyan, Joshi, Ostor, Hall, Rudd, Wilkinson (CR32) 2012; 126 Peluso, Caso, Tasso, Ambrosino, Dario Di Minno, Lupoli (CR2) 2018; 13 Marnane, Merwick, Sheehan, Hannon, Foran, Grant, Dolan, Moroney, Murphy, O'Rourke, O'Malley, O'Donohoe, McDonnell, Noone, Barry, Crowe, Kavanagh, O'Connell, Kelly (CR15) 2012; 71 McHugh, Balachrishnan, Jones (CR5) 2003; 42 Bengel (CR36) 2016; 9 Rudd, Warburton, Fryer, Jones, Clark, Antoun, Johnstrom, Davenport, Kirkpatrick, Arch, Pickard, Weissberg (CR10) 2002; 105 Dey, Joshi, Chaturvedi, Lerman, Aberra, Rodante, Teague, Harrington, Rivers, Chung, Kabbany, Natarajan, Silverman, Ng, Sanda, Sorokin, Baumer, Gerson, Prussick, Ehrlich, Green, Lockshin, Ahlman, Playford, Gelfand, Mehta (CR34) 2017; 2 Schindler, Schelbert, Quercioli, Dilsizian (CR18) 2010; 3 Sankowski, Lebkowska, Cwikla, Walecka, Walecki (CR1) 2013; 78 Naik, Natarajan, Stansky, Ahlman, Teague, Salahuddin, Ng, Joshi, Krishnamoorthy, Dave, Rose, Doveikis, Playford, Prussick, Ehrlich, Kaplan, Lockshin, Gelfand, Mehta (CR8) 2015; 35 Rominger, Saam, Wolpers, Cyran, Schmidt, Foerster, Nikolaou, Reiser, Bartenstein, Hacker (CR14) 2009; 50 Chih, Chong, Erthal, deKemp, Davies, Stadnick, So, Overgaard, Wells, Mielniczuk, Beanlands (CR26) 2018; 71 Fox, Strauss (CR40) 2009; 50 Anagnostopoulos, Almonacid, El Fakhri, Curillova, Sitek, Roughton, Dorbala, Popma, Di Carli (CR22) 2008; 35 Tawakol, Migrino, Bashian, Bedri, Vermylen, Cury, Yates, LaMuraglia, Furie, Houser, Gewirtz, Muller, Brady, Fischman (CR11) 2006; 48 Joseph, Tawakol (CR42) 2016; 37 Puzenat, Bronsard, Prey, Gourraud, Aractingi, Bagot, Cribier, Joly, Jullien, Le Maitre, Paul, Richard-Lallemand, Ortonne, Aubin (CR24) 2010; 24 Figueroa, Abdelbaky, Truong, Corsini, MacNabb, Lavender, Lawler, Grinspoon, Brady, Nasir, Hoffmann, Tawakol (CR13) 2013; 6 Germino, Ropchan, Mulnix, Fontaine, Nabulsi, Ackah, Feringa, Sinusas, Liu, Carson (CR20) 2016; 6 Mehta, Li, Krishnamoorthy, Yu, Farver, Rodrigues, Raper, Wilcox, Baer, DerOhannesian, Wolfe, Reilly, Rader, VanVoorhees, Gelfand (CR30) 2012; 224 Lortie, Beanlands, Yoshinaga, Klein, Dasilva, DeKemp (CR25) 2007; 34 deKemp, Klein, Beanlands (CR19) 2016; 6 Taylor, Gladman, Helliwell, Marchesoni, Mease, Mielants (CR21) 2006; 54 Wu, Li, Niu, Chen (CR41) 2013; 3 Daghem, Newby (CR6) 2018; 11 Mizoguchi, Tahara, Tahara, Nitta, Kodama, Oba, Mawatari, Yasukawa, Kaida, Ishibashi, Hayabuchi, Harada, Ikeda, Yamagishi, Imaizumi (CR17) 2011; 4 Gelfand, Neimann, Shin, Wang, Margolis, Troxel (CR28) 2006; 296 Goff, Karimkhani, Boyers, Weinstock, Lott, Hay, Coffeng, Norton, Naldi, Dunnick, Armstrong, Dellavalle (CR27) 2015; 172 Tawakol, Fayad, Mogg, Alon, Klimas, Dansky, Subramanian, Abdelbaky, Rudd, Farkouh, Nunes, Beals, Shankar (CR16) 2013; 62 Baliwag, Barnes, Johnston (CR7) 2015; 73 Tarkin, Joshi, Rudd (CR38) 2014; 11 Yeung, Takeshita, Mehta, Kimmel, Ogdie, Margolis, Shin, Attor, Troxel, Gelfand (CR3) 2013; 149 Mehta, Shin, Joshi, Dey, Armstrong, Duffin, Fuxench, Harrington, Hubbard, Kalb, Menter, Rader, Reilly, Simpson, Takeshita, Torigian, Werner, Troxel, Tyring, Vanderbeek, Van Voorhees, Playford, Ahlman, Alavi, Gelfand (CR35) 2018; 11 Gelfand, Troxel, Lewis, Kurd, Shin, Wang, Margolis, Strom (CR4) 2007; 143 Mehta, Azfar, Shin, Neimann, Troxel, Gelfand (CR29) 2010; 31 Li, Rosenkrans, Wang, Cai (CR37) 2020; 12 Harrington, Dey, Yunus, Joshi, Mehta (CR31) 2017; 312 Piaserico, Osto, Famoso, Montisci, De Michieli, Zanetti, Iliceto, Tona (CR9) 2019; 289 Joshi, Vesey, Williams, Shah, Calvert, Craighead, Yeoh, Wallace, Salter, Fletcher, van Beek, Flapan, Uren, Behan, Cruden, Mills, Fox, Rudd, Dweck, Newby (CR39) 2014; 383 Kim, Lee, Pak, Han, Kim, Kim, Ko, Kim, Kim (CR33) 2019; 80 Cocker, Spence, Hammond, deKemp, Lum, Wells (CR12) 2018; 271 Khraishi, MacDonald, Rampakakis, Vaillancourt, Sampalis (CR23) 2011; 30 Tawakol (10.1007/s12350-023-03204-8_bib11) 2006; 48 Rudd (10.1007/s12350-023-03204-8_bib10) 2002; 105 Anagnostopoulos (10.1007/s12350-023-03204-8_bib22) 2008; 35 Li (10.1007/s12350-023-03204-8_bib37) 2020; 12 McHugh (10.1007/s12350-023-03204-8_bib5) 2003; 42 Piaserico (10.1007/s12350-023-03204-8_bib9) 2019; 289 Fox (10.1007/s12350-023-03204-8_bib40) 2009; 50 Kim (10.1007/s12350-023-03204-8_bib33) 2019; 80 Bengel (10.1007/s12350-023-03204-8_bib36) 2016; 9 Tarkin (10.1007/s12350-023-03204-8_bib38) 2014; 11 Mizoguchi (10.1007/s12350-023-03204-8_bib17) 2011; 4 Mehta (10.1007/s12350-023-03204-8_bib29) 2010; 31 deKemp (10.1007/s12350-023-03204-8_bib19) 2016; 6 Baliwag (10.1007/s12350-023-03204-8_bib7) 2015; 73 Germino (10.1007/s12350-023-03204-8_bib20) 2016; 6 Harrington (10.1007/s12350-023-03204-8_bib31) 2017; 312 Cocker (10.1007/s12350-023-03204-8_bib12) 2018; 271 Wu (10.1007/s12350-023-03204-8_bib41) 2013; 3 Sankowski (10.1007/s12350-023-03204-8_bib1) 2013; 78 Tawakol (10.1007/s12350-023-03204-8_bib16) 2013; 62 Dey (10.1007/s12350-023-03204-8_bib34) 2017; 2 Daghem (10.1007/s12350-023-03204-8_bib6) 2018; 11 Figueroa (10.1007/s12350-023-03204-8_bib13) 2013; 6 Peluso (10.1007/s12350-023-03204-8_bib2) 2018; 13 Joshi (10.1007/s12350-023-03204-8_bib39) 2014; 383 Yeung (10.1007/s12350-023-03204-8_bib3) 2013; 149 Chih (10.1007/s12350-023-03204-8_bib26) 2018; 71 Joseph (10.1007/s12350-023-03204-8_bib42) 2016; 37 Maki-Petaja (10.1007/s12350-023-03204-8_bib32) 2012; 126 Gelfand (10.1007/s12350-023-03204-8_bib4) 2007; 143 Marnane (10.1007/s12350-023-03204-8_bib15) 2012; 71 Puzenat (10.1007/s12350-023-03204-8_bib24) 2010; 24 Goff (10.1007/s12350-023-03204-8_bib27) 2015; 172 Naik (10.1007/s12350-023-03204-8_bib8) 2015; 35 Khraishi (10.1007/s12350-023-03204-8_bib23) 2011; 30 Taylor (10.1007/s12350-023-03204-8_bib21) 2006; 54 Lortie (10.1007/s12350-023-03204-8_bib25) 2007; 34 Mehta (10.1007/s12350-023-03204-8_bib30) 2012; 224 Gelfand (10.1007/s12350-023-03204-8_bib28) 2006; 296 Rominger (10.1007/s12350-023-03204-8_bib14) 2009; 50 Schindler (10.1007/s12350-023-03204-8_bib18) 2010; 3 Mehta (10.1007/s12350-023-03204-8_bib35) 2018; 11 37127724 - J Nucl Cardiol. 2023 Aug;30(4):1653-1655
References_xml	– volume: 172 start-page: 1665 year: 2015 end-page: 1668 ident: bib27 article-title: The global burden of psoriatic skin disease publication-title: Br J Dermatol – volume: 35 start-page: 2667 year: 2015 end-page: 2676 ident: bib8 article-title: Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study publication-title: Arterioscler Thromb Vasc Biol – volume: 3 start-page: 623 year: 2010 end-page: 640 ident: bib18 article-title: Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health publication-title: JACC Cardiovasc Imaging – volume: 11 year: 2018 ident: bib6 article-title: Psoriasis and inflammation more than skin deep publication-title: Circ Cardiovasc Imaging – volume: 4 start-page: 1110 year: 2011 end-page: 1118 ident: bib17 article-title: Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta publication-title: JACC Cardiovasc Imaging – volume: 50 start-page: 1611 year: 2009 end-page: 1620 ident: bib14 article-title: 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease publication-title: J Nucl Med – volume: 54 start-page: 2665 year: 2006 end-page: 2673 ident: bib21 article-title: Classification criteria for psoriatic arthritis: development of new criteria from a large international study publication-title: Arthritis Rheumatism – volume: 312 start-page: H867 year: 2017 end-page: H873 ident: bib31 article-title: Psoriasis as a human model of disease to study inflammatory atherogenesis publication-title: Am J Physiol Heart Circ Physiol – volume: 9 year: 2016 ident: bib36 article-title: Imaging of post-infarct inflammation: Moving forward toward clinical application publication-title: Circ Cardiovasc Imaging – volume: 6 start-page: 1250 year: 2013 end-page: 1259 ident: bib13 article-title: Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events publication-title: JACC Cardiovasc Imaging – volume: 73 start-page: 342 year: 2015 end-page: 350 ident: bib7 article-title: Cytokines in psoriasis publication-title: Cytokine – volume: 48 start-page: 1818 year: 2006 end-page: 1824 ident: bib11 article-title: In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients publication-title: J Am Coll Cardiol – volume: 62 start-page: 909 year: 2013 end-page: 917 ident: bib16 article-title: Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: Results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study publication-title: J Am Coll Cardiol – volume: 71 start-page: 1444 year: 2018 end-page: 1456 ident: bib26 article-title: PET Assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy publication-title: J Am Coll Cardiol – volume: 78 start-page: 7 year: 2013 end-page: 17 ident: bib1 article-title: Psoriatic arthritis publication-title: Pol J Radiol – volume: 224 start-page: 218 year: 2012 end-page: 221 ident: bib30 article-title: Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis publication-title: Atherosclerosis – volume: 50 start-page: 497 year: 2009 end-page: 500 ident: bib40 article-title: One step closer to imaging vulnerable plaque in the coronary arteries publication-title: J Nucl Med – volume: 105 start-page: 2708 year: 2002 end-page: 2711 ident: bib10 article-title: Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography publication-title: Circulation – volume: 6 start-page: 68 year: 2016 ident: bib20 article-title: Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling publication-title: EJNMMI Res – volume: 31 start-page: 1000 year: 2010 end-page: 1006 ident: bib29 article-title: Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the General Practice Research Database publication-title: Eur Heart J – volume: 11 year: 2018 ident: bib35 article-title: Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: A randomized placebo-controlled trial publication-title: Circ Cardiovasc Imaging – volume: 13 start-page: 199 year: 2018 end-page: 209 ident: bib2 article-title: Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients publication-title: Rev Recent Clin Trials – volume: 296 start-page: 1735 year: 2006 end-page: 1741 ident: bib28 article-title: Risk of myocardial infarction in patients with psoriasis publication-title: JAMA – volume: 30 start-page: 877 year: 2011 end-page: 885 ident: bib23 article-title: Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts publication-title: Clin Rheumatol – volume: 80 start-page: 1322 year: 2019 end-page: 1331 ident: bib33 article-title: Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using (18)F-fluorodeoxyglucose PET/CT publication-title: J Am Acad Dermatol – volume: 2 start-page: 1013 year: 2017 end-page: 1018 ident: bib34 article-title: Association between skin and aortic vascular inflammation in patients with psoriasis: A case-cohort study using positron emission tomography/computed tomography publication-title: JAMA Cardiol – volume: 149 start-page: 1173 year: 2013 end-page: 1179 ident: bib3 article-title: Psoriasis severity and the prevalence of major medical comorbidity: A population-based study publication-title: JAMA Dermatol – volume: 42 start-page: 778 year: 2003 end-page: 783 ident: bib5 article-title: Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study publication-title: Rheumatology (Oxford) – volume: 3 start-page: 448 year: 2013 end-page: 466 ident: bib41 article-title: PET imaging of inflammation biomarkers publication-title: Theranostics – volume: 37 start-page: 2974 year: 2016 end-page: 2980 ident: bib42 article-title: Imaging atherosclerosis with positron emission tomography publication-title: Eur Heart J – volume: 11 start-page: 443 year: 2014 end-page: 457 ident: bib38 article-title: PET imaging of inflammation in atherosclerosis publication-title: Nat Rev Cardiol – volume: 12 start-page: 1491 year: 2020 end-page: 1514 ident: bib37 article-title: PET imaging of macrophages in cardiovascular diseases publication-title: Am J Transl Res – volume: 35 start-page: 1593 year: 2008 end-page: 1601 ident: bib22 article-title: Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity publication-title: Eur J Nucl Med Mol Imaging – volume: 34 start-page: 1765 year: 2007 end-page: 1774 ident: bib25 article-title: Quantification of myocardial blood flow with 82Rb dynamic PET imaging publication-title: Eur J Nucl Med Mol Imaging – volume: 126 start-page: 2473 year: 2012 end-page: 2480 ident: bib32 article-title: Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis publication-title: Circulation – volume: 71 start-page: 709 year: 2012 end-page: 718 ident: bib15 article-title: Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence publication-title: Ann Neurol – volume: 383 start-page: 705 year: 2014 end-page: 713 ident: bib39 article-title: 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial publication-title: Lancet – volume: 271 start-page: 378 year: 2018 end-page: 386 ident: bib12 article-title: [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events publication-title: Int J Cardiol – volume: 143 start-page: 1493 year: 2007 end-page: 1499 ident: bib4 article-title: The risk of mortality in patients with psoriasis: Results from a population-based study publication-title: Arch Dermatol – volume: 289 start-page: 57 year: 2019 end-page: 63 ident: bib9 article-title: Long-term prognostic value of coronary flow reserve in psoriasis patients publication-title: Atherosclerosis – volume: 24 start-page: 10 year: 2010 end-page: 16 ident: bib24 article-title: What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature publication-title: J Eur Acad Dermatol Venereol – volume: 6 start-page: 69 year: 2016 ident: bib19 article-title: (82)Rb PET imaging of myocardial blood flow-have we achieved the 4 “R”s to support routine use? publication-title: EJNMMI Res – volume: 149 start-page: 1173 year: 2013 end-page: 1179 ident: CR3 article-title: Psoriasis severity and the prevalence of major medical comorbidity: A population-based study publication-title: JAMA Dermatol – volume: 4 start-page: 1110 year: 2011 end-page: 1118 ident: CR17 article-title: Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta publication-title: JACC Cardiovasc Imaging – volume: 54 start-page: 2665 year: 2006 end-page: 73 ident: CR21 article-title: Classification criteria for psoriatic arthritis: development of new criteria from a large international study publication-title: Arthritis Rheumatism – volume: 71 start-page: 709 year: 2012 end-page: 718 ident: CR15 article-title: Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence publication-title: Ann Neurol – volume: 80 start-page: 1322 year: 2019 end-page: 1331 ident: CR33 article-title: Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using (18)F-fluorodeoxyglucose PET/CT publication-title: J Am Acad Dermatol – volume: 2 start-page: 1013 year: 2017 end-page: 1018 ident: CR34 article-title: Association between skin and aortic vascular inflammation in patients with psoriasis: A case-cohort study using positron emission tomography/computed tomography publication-title: JAMA Cardiol – volume: 34 start-page: 1765 year: 2007 end-page: 1774 ident: CR25 article-title: Quantification of myocardial blood flow with 82Rb dynamic PET imaging publication-title: Eur J Nucl Med Mol Imaging – volume: 31 start-page: 1000 year: 2010 end-page: 1006 ident: CR29 article-title: Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the General Practice Research Database publication-title: Eur Heart J – volume: 50 start-page: 497 year: 2009 end-page: 500 ident: CR40 article-title: One step closer to imaging vulnerable plaque in the coronary arteries publication-title: J Nucl Med – volume: 3 start-page: 448 year: 2013 end-page: 466 ident: CR41 article-title: PET imaging of inflammation biomarkers publication-title: Theranostics – volume: 383 start-page: 705 year: 2014 end-page: 713 ident: CR39 article-title: 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial publication-title: Lancet – volume: 172 start-page: 1665 year: 2015 end-page: 1668 ident: CR27 article-title: The global burden of psoriatic skin disease publication-title: Br J Dermatol – volume: 126 start-page: 2473 year: 2012 end-page: 2480 ident: CR32 article-title: Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis publication-title: Circulation – volume: 11 year: 2018 ident: CR35 article-title: Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: A randomized placebo-controlled trial publication-title: Circ Cardiovasc Imaging – volume: 30 start-page: 877 year: 2011 end-page: 885 ident: CR23 article-title: Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts publication-title: Clin Rheumatol – volume: 105 start-page: 2708 year: 2002 end-page: 2711 ident: CR10 article-title: Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography publication-title: Circulation – volume: 11 start-page: 443 year: 2014 end-page: 457 ident: CR38 article-title: PET imaging of inflammation in atherosclerosis publication-title: Nat Rev Cardiol – volume: 289 start-page: 57 year: 2019 end-page: 63 ident: CR9 article-title: Long-term prognostic value of coronary flow reserve in psoriasis patients publication-title: Atherosclerosis – volume: 48 start-page: 1818 year: 2006 end-page: 1824 ident: CR11 article-title: In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients publication-title: J Am Coll Cardiol – volume: 50 start-page: 1611 year: 2009 end-page: 1620 ident: CR14 article-title: 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease publication-title: J Nucl Med – volume: 62 start-page: 909 year: 2013 end-page: 917 ident: CR16 article-title: Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: Results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study publication-title: J Am Coll Cardiol – volume: 6 start-page: 68 year: 2016 ident: CR20 article-title: Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling publication-title: EJNMMI Res – volume: 312 start-page: H867 year: 2017 end-page: H873 ident: CR31 article-title: Psoriasis as a human model of disease to study inflammatory atherogenesis publication-title: Am J Physiol Heart Circ Physiol – volume: 6 start-page: 1250 year: 2013 end-page: 1259 ident: CR13 article-title: Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events publication-title: JACC Cardiovasc Imaging – volume: 73 start-page: 342 year: 2015 end-page: 350 ident: CR7 article-title: Cytokines in psoriasis publication-title: Cytokine – volume: 35 start-page: 2667 year: 2015 end-page: 2676 ident: CR8 article-title: Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study publication-title: Arterioscler Thromb Vasc Biol – volume: 6 start-page: 69 year: 2016 ident: CR19 article-title: (82)Rb PET imaging of myocardial blood flow-have we achieved the 4 “R”s to support routine use? publication-title: EJNMMI Res – volume: 296 start-page: 1735 year: 2006 end-page: 1741 ident: CR28 article-title: Risk of myocardial infarction in patients with psoriasis publication-title: JAMA – volume: 11 year: 2018 ident: CR6 article-title: Psoriasis and inflammation more than skin deep publication-title: Circ Cardiovasc Imaging – volume: 224 start-page: 218 year: 2012 end-page: 221 ident: CR30 article-title: Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis publication-title: Atherosclerosis – volume: 9 year: 2016 ident: CR36 article-title: Imaging of post-infarct inflammation: Moving forward toward clinical application publication-title: Circ Cardiovasc Imaging – volume: 35 start-page: 1593 year: 2008 end-page: 1601 ident: CR22 article-title: Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity publication-title: Eur J Nucl Med Mol Imaging – volume: 271 start-page: 378 year: 2018 end-page: 386 ident: CR12 article-title: [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events publication-title: Int J Cardiol – volume: 37 start-page: 2974 year: 2016 end-page: 2980 ident: CR42 article-title: Imaging atherosclerosis with positron emission tomography publication-title: Eur Heart J – volume: 13 start-page: 199 year: 2018 end-page: 209 ident: CR2 article-title: Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients publication-title: Rev Recent Clin Trials – volume: 42 start-page: 778 year: 2003 end-page: 783 ident: CR5 article-title: Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study publication-title: Rheumatology (Oxford) – volume: 143 start-page: 1493 year: 2007 end-page: 1499 ident: CR4 article-title: The risk of mortality in patients with psoriasis: Results from a population-based study publication-title: Arch Dermatol – volume: 71 start-page: 1444 year: 2018 end-page: 1456 ident: CR26 article-title: PET Assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy publication-title: J Am Coll Cardiol – volume: 3 start-page: 623 year: 2010 end-page: 640 ident: CR18 article-title: Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health publication-title: JACC Cardiovasc Imaging – volume: 12 start-page: 1491 year: 2020 end-page: 1514 ident: CR37 article-title: PET imaging of macrophages in cardiovascular diseases publication-title: Am J Transl Res – volume: 24 start-page: 10 issue: Suppl 2 year: 2010 end-page: 16 ident: CR24 article-title: What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature publication-title: J Eur Acad Dermatol Venereol – volume: 78 start-page: 7 year: 2013 end-page: 17 ident: CR1 article-title: Psoriatic arthritis publication-title: Pol J Radiol – volume: 3 start-page: 623 year: 2010 ident: 10.1007/s12350-023-03204-8_bib18 article-title: Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2010.04.007 – volume: 383 start-page: 705 year: 2014 ident: 10.1007/s12350-023-03204-8_bib39 article-title: 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial publication-title: Lancet doi: 10.1016/S0140-6736(13)61754-7 – volume: 9 year: 2016 ident: 10.1007/s12350-023-03204-8_bib36 article-title: Imaging of post-infarct inflammation: Moving forward toward clinical application publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.116.004713 – volume: 73 start-page: 342 year: 2015 ident: 10.1007/s12350-023-03204-8_bib7 article-title: Cytokines in psoriasis publication-title: Cytokine doi: 10.1016/j.cyto.2014.12.014 – volume: 6 start-page: 69 year: 2016 ident: 10.1007/s12350-023-03204-8_bib19 article-title: (82)Rb PET imaging of myocardial blood flow-have we achieved the 4 “R”s to support routine use? publication-title: EJNMMI Res doi: 10.1186/s13550-016-0225-4 – volume: 54 start-page: 2665 year: 2006 ident: 10.1007/s12350-023-03204-8_bib21 article-title: Classification criteria for psoriatic arthritis: development of new criteria from a large international study publication-title: Arthritis Rheumatism doi: 10.1002/art.21972 – volume: 11 year: 2018 ident: 10.1007/s12350-023-03204-8_bib6 article-title: Psoriasis and inflammation more than skin deep publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.118.007849 – volume: 50 start-page: 497 year: 2009 ident: 10.1007/s12350-023-03204-8_bib40 article-title: One step closer to imaging vulnerable plaque in the coronary arteries publication-title: J Nucl Med doi: 10.2967/jnumed.108.056325 – volume: 224 start-page: 218 year: 2012 ident: 10.1007/s12350-023-03204-8_bib30 article-title: Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.06.068 – volume: 35 start-page: 2667 year: 2015 ident: 10.1007/s12350-023-03204-8_bib8 article-title: Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.115.306460 – volume: 71 start-page: 1444 year: 2018 ident: 10.1007/s12350-023-03204-8_bib26 article-title: PET Assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.01.062 – volume: 149 start-page: 1173 year: 2013 ident: 10.1007/s12350-023-03204-8_bib3 article-title: Psoriasis severity and the prevalence of major medical comorbidity: A population-based study publication-title: JAMA Dermatol doi: 10.1001/jamadermatol.2013.5015 – volume: 48 start-page: 1818 year: 2006 ident: 10.1007/s12350-023-03204-8_bib11 article-title: In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.05.076 – volume: 3 start-page: 448 year: 2013 ident: 10.1007/s12350-023-03204-8_bib41 article-title: PET imaging of inflammation biomarkers publication-title: Theranostics doi: 10.7150/thno.6592 – volume: 11 year: 2018 ident: 10.1007/s12350-023-03204-8_bib35 article-title: Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: A randomized placebo-controlled trial publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.117.007394 – volume: 34 start-page: 1765 year: 2007 ident: 10.1007/s12350-023-03204-8_bib25 article-title: Quantification of myocardial blood flow with 82Rb dynamic PET imaging publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-007-0478-2 – volume: 143 start-page: 1493 year: 2007 ident: 10.1007/s12350-023-03204-8_bib4 article-title: The risk of mortality in patients with psoriasis: Results from a population-based study publication-title: Arch Dermatol doi: 10.1001/archderm.143.12.1493 – volume: 289 start-page: 57 year: 2019 ident: 10.1007/s12350-023-03204-8_bib9 article-title: Long-term prognostic value of coronary flow reserve in psoriasis patients publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2019.08.009 – volume: 312 start-page: H867 year: 2017 ident: 10.1007/s12350-023-03204-8_bib31 article-title: Psoriasis as a human model of disease to study inflammatory atherogenesis publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00774.2016 – volume: 105 start-page: 2708 year: 2002 ident: 10.1007/s12350-023-03204-8_bib10 article-title: Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography publication-title: Circulation doi: 10.1161/01.CIR.0000020548.60110.76 – volume: 296 start-page: 1735 year: 2006 ident: 10.1007/s12350-023-03204-8_bib28 article-title: Risk of myocardial infarction in patients with psoriasis publication-title: JAMA doi: 10.1001/jama.296.14.1735 – volume: 6 start-page: 1250 year: 2013 ident: 10.1007/s12350-023-03204-8_bib13 article-title: Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2013.08.006 – volume: 30 start-page: 877 year: 2011 ident: 10.1007/s12350-023-03204-8_bib23 article-title: Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts publication-title: Clin Rheumatol doi: 10.1007/s10067-011-1692-7 – volume: 4 start-page: 1110 year: 2011 ident: 10.1007/s12350-023-03204-8_bib17 article-title: Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2011.08.007 – volume: 126 start-page: 2473 year: 2012 ident: 10.1007/s12350-023-03204-8_bib32 article-title: Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.120410 – volume: 50 start-page: 1611 year: 2009 ident: 10.1007/s12350-023-03204-8_bib14 article-title: 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease publication-title: J Nucl Med doi: 10.2967/jnumed.109.065151 – volume: 6 start-page: 68 year: 2016 ident: 10.1007/s12350-023-03204-8_bib20 article-title: Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling publication-title: EJNMMI Res doi: 10.1186/s13550-016-0215-6 – volume: 13 start-page: 199 year: 2018 ident: 10.1007/s12350-023-03204-8_bib2 article-title: Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients publication-title: Rev Recent Clin Trials doi: 10.2174/1574887113666180314105511 – volume: 12 start-page: 1491 year: 2020 ident: 10.1007/s12350-023-03204-8_bib37 article-title: PET imaging of macrophages in cardiovascular diseases publication-title: Am J Transl Res – volume: 80 start-page: 1322 year: 2019 ident: 10.1007/s12350-023-03204-8_bib33 article-title: Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using (18)F-fluorodeoxyglucose PET/CT publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2018.03.011 – volume: 271 start-page: 378 year: 2018 ident: 10.1007/s12350-023-03204-8_bib12 article-title: [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2018.05.057 – volume: 35 start-page: 1593 year: 2008 ident: 10.1007/s12350-023-03204-8_bib22 article-title: Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-008-0793-2 – volume: 24 start-page: 10 issue: Suppl 2 year: 2010 ident: 10.1007/s12350-023-03204-8_bib24 article-title: What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2009.03562.x – volume: 71 start-page: 709 year: 2012 ident: 10.1007/s12350-023-03204-8_bib15 article-title: Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence publication-title: Ann Neurol doi: 10.1002/ana.23553 – volume: 11 start-page: 443 year: 2014 ident: 10.1007/s12350-023-03204-8_bib38 article-title: PET imaging of inflammation in atherosclerosis publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2014.80 – volume: 31 start-page: 1000 year: 2010 ident: 10.1007/s12350-023-03204-8_bib29 article-title: Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the General Practice Research Database publication-title: Eur Heart J doi: 10.1093/eurheartj/ehp567 – volume: 78 start-page: 7 year: 2013 ident: 10.1007/s12350-023-03204-8_bib1 article-title: Psoriatic arthritis publication-title: Pol J Radiol doi: 10.12659/PJR.883763 – volume: 2 start-page: 1013 year: 2017 ident: 10.1007/s12350-023-03204-8_bib34 article-title: Association between skin and aortic vascular inflammation in patients with psoriasis: A case-cohort study using positron emission tomography/computed tomography publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2017.1213 – volume: 37 start-page: 2974 year: 2016 ident: 10.1007/s12350-023-03204-8_bib42 article-title: Imaging atherosclerosis with positron emission tomography publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw147 – volume: 172 start-page: 1665 year: 2015 ident: 10.1007/s12350-023-03204-8_bib27 article-title: The global burden of psoriatic skin disease publication-title: Br J Dermatol doi: 10.1111/bjd.13715 – volume: 62 start-page: 909 year: 2013 ident: 10.1007/s12350-023-03204-8_bib16 article-title: Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: Results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.04.066 – volume: 42 start-page: 778 year: 2003 ident: 10.1007/s12350-023-03204-8_bib5 article-title: Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keg217 – reference: 37127724 - J Nucl Cardiol. 2023 Aug;30(4):1653-1655
SSID	ssj0009399
Score	2.405438
Snippet	The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by... Aim The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by... The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by Rb... AimThe aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by...
SourceID	pubmedcentral proquest pubmed crossref springer elsevier
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1642
SubjectTerms	Anti-Inflammatory Agents - therapeutic use Arthritis, Psoriatic - diagnostic imaging Arthritis, Psoriatic - drug therapy Biological Factors - therapeutic use Cardiology cardiovascular disease Coronary vessels Fluorodeoxyglucose F18 - therapeutic use Humans Imaging inflammation Inflammation - diagnostic imaging Medicine Medicine & Public Health Nuclear Medicine Original Original Article PET imaging Positron-Emission Tomography Prospective Studies Psoriasis Psoriasis - diagnostic imaging Psoriasis - drug therapy Psoriatic arthritis Radiology
Title	Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study
URI	https://dx.doi.org/10.1007/s12350-023-03204-8 https://link.springer.com/article/10.1007/s12350-023-03204-8 https://www.ncbi.nlm.nih.gov/pubmed/36754934 https://www.proquest.com/docview/2842543035 https://www.proquest.com/docview/2774895615 https://pubmed.ncbi.nlm.nih.gov/PMC10372102
Volume	30
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELWglRAXxDeBUhmJG1hsYju2uaXLbitQKw5dqZys2HHESpCtNumh_74zibOrtrQSlyRSJpGTN5MZZzxvCPnofBYq50sG37qKCe49c0GnLC8hOgAHV6cpViMfn-RHC_H9TJ5FmhyshbmRv__SYi3nhIFnYdjqWzD9kOzKlCts0zDNp1uCXd73ioTZTMqQ0ysWyPz7Hnc5odtB5u21kjcSpr0fmj8lT2IASYsB8WfkQWiek0fHMUX-grRF0y0Z6A1A_bdPodNhzQZd1XSgXFp6OpRdXdJlQyOzakvxlyw9b1drRMvTmLr5SgsK4x0rMil21F13dP7tkP6cndKenvYlWcxnp9MjFjsrMC8z3QEcLsu1N2DPCo6V0F6VximIdoIpOa-8rGqvjKlLXk0mtdSqysuQ1x756pXmr8hOs2rCG0JNEMbVPqtd7oWrjMlkFfKQhtRpqYNPSDq-ausj7Th2v_hjt4TJCI8FeGwPj9UJ-bS55nwg3bhXWo4I2hg2DOGABWW697q9EW4bDbe1GaYlBfh1mZAPm9NgcphHKZuwugAZhZQ9EHiCzOtBOzbD5DABE4aLhOhrerMRQDrv62ea5e-e1hsrNnECnpDPo4ptx3X3Y7z9P_F35HHWWwKuYdwjO936IryHuKpz-2S3mB8cnOD-8NeP2X5vYLBdZMUVD-Mc3w
linkProvider	Springer Nature
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nj9MwEB3BIgEXxDeBBYzEDSw1_khsbhVsKbBdcWilvVmx44hKkK6a7IF_z9hxWi3LrsStUiaV2zeTec543gC8tY752rqK4rOupoI7R61XOS0qZAeY4Jo8D93Ii5NivhJfT-VpagrrxtPuY0kyPqn3zW6MywnFHEPD0G9B1U24hWRABV9eseleapfHqZG4r8lpUPdKrTL__o6r0tFlunn51ORfpdOYkWb34V6ikmQ6YP8Abvj2IdxepGL5I-imbb-m6EEI-q9YTCfD6Q2yacggvrR2ZGjA-k3WLUkaqx0JL2fJWbfZBtwcSUWcD2RKcL1jbyYJs3W3PZl9-ky-Hy1JFKp9DKvZ0fLjnKYZC9RJpnoExrJCOY2RXeLnUihXVtqWyHu8rjivnawbV2rdVLyeTBqpyrqofNG4oFxfKv4EDtpN658B0V5o2zjW2MIJW2vNZO0Ln_vcKqm8yyAf_2rjkgB5mIPx0-ylkwM8BuExER6jMni3u-dskN-41lqOCJpEIAZiYDA_XHvf4Qi3SSHcGRYKlAIzvMzgze4yBl-oqFSt35yjTRnEe5CCos3TwTt2y-S4FROaiwzUBb_ZGQRh74tX2vWPKPAdejfDVjyD96OL7dd19c94_n_mr-HOfLk4NsdfTr69gLssRkU42XgIB_323L9EttXbVzG4_gBmDh_9
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9QwDI9gSBMviG86BgSJN4h2bZM24e102zE-Nu1hk_YWNV_aSdA73XUP---x0_SOMTaJt0pxqrS2a7u2fybkg7GFd8Y2DL51jvHSWma8zFnVgHcABi7kOXYjHx1Xh2f827k4_6OLP1a7DynJvqcBUZrabm_hwt6m8a0oxYiBvWE4AJwzeZ88gEglx_BrUk02sLtlnCAJMU7OEOkrtc38-x63maabrufNCsq_0qjROk0fk0fJraTjXg6ekHu-fUq2j1Li_BlZjdtuxkCaQAB-xcQ67Ss56DzQHohpZmnfjHVFZy1NeKsrij9q6WI1XyIPLU0Jnc90TOG8Q58mxTm7y45O97_Qk4NTGkFrn5Oz6cHp5JCleQvMikJ2wCRTVNIq0PIarmsubd0oU4MP5FVTls4KF2ytVGhKNxoFIWtXNb4KFlHsa1m-IFvtvPWvCFWeKxNsEUxluXFKFcL5yuc-N1JIbzOSD69a2wRGjjMxfuoNjDKyRwN7dGSPlhn5uN6z6KE47qQWAwd1ciZ6J0GDrbhz3-7Abp3UeaULTFZysPYiI-_Xy6CImF1pWj-_BJoagXzAHQWal710rI9ZQljGVckzIq_JzZoAQb6vr7Sziwj2jX2cGJZn5NMgYptz3f4YO_9H_o5sn-xP9Y-vx99fk4dFVAosctwlW93y0r8Bx6szb6Nu_QZ6PiQj
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-inflammatory+effect+of+biologic+therapy+in+patients+with+psoriatic+disease%3A+A+prospective+cohort+FDG+PET+study&rft.jtitle=Journal+of+nuclear+cardiology&rft.au=Boczar%2C+Kevin+E.&rft.au=Beanlands%2C+Rob+S.&rft.au=Glassman%2C+Steven+J.&rft.au=Wang%2C+Jerry&rft.date=2023-08-01&rft.pub=Springer+International+Publishing&rft.issn=1071-3581&rft.eissn=1532-6551&rft.volume=30&rft.issue=4&rft.spage=1642&rft.epage=1652&rft_id=info:doi/10.1007%2Fs12350-023-03204-8&rft_id=info%3Apmid%2F36754934&rft.externalDocID=PMC10372102
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-3581&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-3581&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-3581&client=summon